Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
03/2004
03/04/2004CA2495377A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders
03/03/2004EP1394160A1 Process for preparing crystalline paroxetin hydrochloride
03/03/2004EP1393728A1 Inverse agonists acting at virus-encoded G protein-coupled receptors
03/03/2004EP1392694A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors
03/03/2004EP1392679A1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method and intermediate products for the production thereof and medicament containing said compounds
03/03/2004EP1392639A1 Pyruvate derivatives
03/03/2004EP1392303A2 Polymorphs of fexofenadine hydrochloride
03/03/2004EP1048653B1 Donepezil polycrystals and process for producing the same
03/03/2004EP1045839B1 Novel amines as pharmaceutical agents
03/03/2004EP0865430B1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists
03/03/2004CN1479724A Pyridione derivatives for tretment of atherosclerosis
03/03/2004CN1479723A Method for preparing 4-haloalkyl nicotine nitriles
03/03/2004CN1479722A Guanidine and amidine derivatives as factor Xa inhibitors
03/03/2004CN1479617A N-methyl-D-aspartate receptor agonist pharmaceutical compositions
03/03/2004CN1478779A Tosylate and benzene sulfonate of pyrazolopy ridone compound
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
03/03/2004CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/03/2004CN1140511C Amino piperidine derivatives as integrin alphabeta 3 antagonists
03/02/2004US6700012 Antihistaminic piperidine derivatives and intermediates for the preparation thereof
03/02/2004US6699990 Colorfastness; waterproofing; oxidative color hair dyes
03/02/2004US6699988 By reacting phosgene and lactam in the presence of a non-nucleophilic aliphatic tertiary amine, such as n,n-diisopropylethylamine; high purity, good yields
03/02/2004US6699893 Glucocorticoid receptor modulators
03/02/2004US6699892 Pharmaceutically acceptable salt of amlodipine and method of preparing the same
03/02/2004US6699891 Npyy5 antagonists
03/02/2004US6699890 Phosphodiesterase 4 inhibitors
03/02/2004US6699881 Thiol compounds, their production and use
03/02/2004US6699298 Long chain hindered amines and compositions stabilized therewith
03/02/2004CA2189007C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
02/2004
02/26/2004WO2004016591A1 Process for the preparation of stabilizers for polymers
02/26/2004WO2004016589A2 Process for production of highly pure donepezil hydrochloride
02/26/2004WO2004016576A1 Fused benzene derivative and use
02/26/2004WO2003097855A3 Small molecule inhibitors of her2 expression
02/26/2004WO2003096991A3 Amelioration of the development of cataracts and other opthalmic diseases
02/26/2004WO2002101003A3 Stereoselective preparation of cyclic l-amino acids
02/26/2004WO2002096351A3 Ultrashort-acting opioids for transdermal application
02/26/2004US20040039206 Process for resolving racemic mixtures of piperidine derivatives
02/26/2004US20040039205 Novel processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto
02/26/2004US20040039064 Treating and/or preventing alzheimer's disease and other neurodegenerative diseases; beta-secretase inhibitors
02/26/2004US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease
02/26/2004US20040039022 Storage stable mixtures of (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol, water, buffers and chelate compounds used as neuroprotectants
02/26/2004US20040038966 Cyclic amine derivatives and use thereof
02/26/2004US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours
02/26/2004US20040038857 Treating the cell with a cholinergic agonist in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from the cell, wherein the cell is a macrophage
02/26/2004DE20215415U1 Wasserlösliche Medikamentenvorstufen von Propofol Water-soluble prodrugs of propofol
02/26/2004DE10236868A1 New (hetero)aryl-substituted carboxamide compounds, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors
02/26/2004CA2495383A1 Fused benzene derivative and use
02/25/2004EP1391453A1 Pyroglutamic acid salt of amlodipine
02/25/2004EP1391452A1 4-hydroxpiperidine derivative with analgetic activity
02/25/2004EP1390361A2 Melanocortin receptor ligands
02/25/2004EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
02/25/2004EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
02/25/2004EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
02/25/2004EP1140807B1 Method for preparing nitroxides
02/25/2004EP1005446B1 N-aroylphenylalanine derivatives
02/25/2004EP0981526B1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
02/25/2004EP0883405B1 Amidino protease inhibitors
02/25/2004CN1478076A MCH antagonists and their use in treatment of obesity
02/24/2004US6696570 Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same
02/24/2004US6696469 For treatment of diseases or pathological conditions in which endothelial dysfunction is known; atherosclerosis, dyslipidaemia, diabetes
02/24/2004US6696449 Control degradation of conencting tissue; cardiovascular disorders
02/24/2004US6696443 Piperidine/piperazine-type inhibitors of p38 kinase
02/24/2004US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
02/19/2004WO2004014999A1 Beta-nucleating, light stabilizing agents for polypropylene
02/19/2004WO2004014859A2 Process for preparing quinolin antibiotic intermediates
02/19/2004WO2004014851A2 Tyrosine kinase inhibitors
02/19/2004WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation
02/19/2004WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
02/19/2004WO2004014425A1 Activators of small conductance calcium activated potassium channels and use thereof
02/19/2004WO2004014310A2 Novel processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto
02/19/2004WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators
02/19/2004US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin
02/19/2004US20040034104 2,2-Diphenylbutanamide derivatives and medicines containing the same
02/19/2004US20040034103 Cdc25 photophatase inhibitors
02/19/2004US20040034072 Aza-amino acid derivatives (factor Xa inhibitors 15)
02/19/2004US20040034063 Antiallergens for treating and prevention of asthma
02/19/2004US20040034059 A dosage concentration about 0.4 to 75 mg/mL of fentanyl in water, for the pain treatment
02/19/2004US20040034058 Inhalation asthma treatment with an aqueous solution of (2S)-3-(4-(((4-(aminocarbonyl)-1-piperidinyl)carbonyl)oxy) phenyl)-2-(((2S)-4-methyl-2-((2-(2-methylphenoxy)acetyl)amino) pentanoyl)amino) propanoic acid or a salt
02/19/2004US20040034057 Salt formation by dissolving donepezil in ethanol, adding hydrogen chloride, forming polymorphic crystal
02/19/2004US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
02/19/2004US20040034035 Calcium channel inhibitors comprising benzhydril spaced from piperazine
02/19/2004US20040034031 3,4-Disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines
02/19/2004US20040034019 Piperazine and piperidine derivatives
02/19/2004US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
02/19/2004US20040033986 Anti tubercular drug: compositions and methods
02/19/2004CA2493660A1 Process for preparing quinolin antibiotic intermediates
02/19/2004CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation
02/19/2004CA2491389A1 Beta-nucleating, light stabilizing agents for polypropylene
02/18/2004EP1389611A1 20-hydroxyeicosatetraenoic acid production inhibitors
02/18/2004EP1389194A2 Inhibitors of bace
02/18/2004EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
02/18/2004EP1389188A1 Method for the production of biperiden ii
02/18/2004EP1389185A2 Aminoalcohol derivatives
02/18/2004EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
02/18/2004EP1213281B1 Novel amide derivatives
02/18/2004EP1178958B1 N-cyanomethyl amides as protease inhibitors
02/18/2004EP0946166B1 Use of matrix metalloproteinase inhibitors for promoting wound healing
02/18/2004EP0918781B1 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral phosphine ligands
02/18/2004EP0839134B1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response
02/18/2004CN1476434A Novel compounds
02/18/2004CN1476433A Substituted benzene derivatives or salts thereof